Medicamentos de actualidad = Drugs of today

• 

  Año 2017, Vol. 53, Número 1

  • LETTER FROM THE MANAGING EDITOR

    • Letter from the Managing Editor

      págs. 5-6

      

  • MONOGRAPHS

    • Daclizumab and its use in multiple sclerosis treatment.

      R. Milo, V. I. Osherov

      • Resumen

      págs. 7-18

      

    • Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension.

      David M. Paton

      • Resumen

      págs. 19-26

      

  • REVIEW

    • The year's new drugs & biologics 2016: Part I

      Ann I. Graul, P. Pina, Elisabet Cruces, Mark Stringer

      • Resumen

      págs. 27-74

      

  • INSIGHT

    • Notable deals in the pharmaceutical industry in the fourth quarter of 2016

      P D'Souza

      • Resumen

      págs. 75-82

      

  • NEW PRODUCT INTROS

    • New product intros (carteolol hydrochloride/latanoprost [new combination]; glycopyrrolate/formoterol fumarate [new combination]; lixisenatide/insulin glargine [new combination]; nusinersen [first-in-class]; rucaparib camsylate.

      pág. 83